Gitelman Syndrome; Gtlmns
Description
Gitelman syndrome is an autosomal recessive renal tubular salt-wasting disorder characterized by hypokalemic metabolic alkalosis with hypomagnesemia and hypocalciuria. It is the most common renal tubular disorder among Caucasians (prevalence of 1 in 40,000). Most patients have onset of symptoms as adults, but some can present in childhood. Clinical features include transient periods of muscle weakness and tetany, abdominal pains, and chondrocalcinosis (summary by Glaudemans et al., 2012). Gitelman syndrome is sometimes referred to as a mild variant of classic Bartter syndrome (OMIM ).For a discussion of genetic heterogeneity of Bartter syndrome, see {607364}.
Clinical Features
Top most frequent phenotypes and symptoms related to Gitelman Syndrome; Gtlmns
- Seizures
- Short stature
- Generalized hypotonia
- Ataxia
- Growth delay
- Failure to thrive
- Muscle weakness
- Pain
- Hypertension
- Fever
And another 57 symptoms. If you need more information about this disease we can help you.
Incidence and onset information
— Currently we don't have prevalence information about this disease (Not enough data available about incidence and published cases.)— No data available about the known clinical features onset.
Alternative names
Gitelman Syndrome; Gtlmns Is also known as hypomagnesemia-hypokalemia, primary renotubular, with hypocalciuria, potassium and magnesium depletion.
Researches and researchers
Currently, we don't have any information about doctors, researches or researchers related to this disease. Please contact us if you would like to appear here.Gitelman Syndrome; Gtlmns Recommended genes panels
Panel Name, Specifity and genes Tested/covered |
---|
![]() By Athena Diagnostics Inc (United States).
CLCNKB
Specificity
100 %
Genes
50 % |
![]() By Athena Diagnostics Inc (United States).
SLC12A1, SLC12A3, BSND, CLCNKB, KCNJ1
Specificity
40 %
Genes
100 % |
![]() By Greenwood Genetic Center Diagnostic Laboratories Greenwood Genetic Center (United States).
RIT1, RPL11, RPL35A, RPL5, RPS10, RPS17, RPS19, RPS24, RPS26, SEC23B, SLC17A5, BRAF, SMPD1, SOS1, SOS2, SOX18, UROS, CBL, SHOC2, ALG9 , (...)
View the complete list with 66 more genes
Specificity
2 %
Genes
50 % |
![]() By Cincinnati Children's Hospital Medical Center Laboratory of Genetics and Genomics Cincinnati Children's Hospital Medical Center (United States).
CLCNKB
Specificity
100 %
Genes
50 % |
![]() By Laboratory for Molecular Medicine Partners HealthCare Personalized Medicine (United States).
SCNN1A, SCNN1B, SLC12A1, SLC12A3, SLC2A2, VDR, WNK4, CASR, BSND, CDC73, SLC22A12, CLCN5, CLCNKB, SLC34A3, CLDN16, CLDN19, FAM20C, FAM20A, HOGA1, CTNS , (...)
View the complete list with 28 more genes
Specificity
5 %
Genes
100 % |
![]() By Instituto de Medicina Genomica Instituto de Medicina Genomica (Spain).
CLCNKB
Specificity
100 %
Genes
50 % |
![]() By CGC Genetics (Portugal).
CLCNKB
Specificity
100 %
Genes
50 % |
![]() By CGC Genetics (Portugal).
CNNM2, SLC12A3, HNF1B, CASR, BSND, SARS2, TRPM6, CLCNKB, CLDN16, CLDN19, FAM111A, EGF, EGFR, FXYD2, KCNA1, KCNJ10, PCBD1
Specificity
12 %
Genes
100 % |
You can get up to 68 more panels with our dedicated tool
Learn moreSources and references
You can check the following sources for additional information.
ORPHANET OMIM MESH Genetic Syndrome FinderIf you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like RHABDOID TUMOR PREDISPOSITION SYNDROME 1; RTPS1 NEUROBLASTOMA, SUSCEPTIBILITY TO EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 17; EIEE17 MUSCULAR DYSTROPHY, DUCHENNE TYPE; DMD